Biggest News Aggregation in the World
📰 Looking Statement News

Page 11 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Merck Announces Phase 3 Trial Initiations for Four Investigational Candidates From its Promising Hematology and Oncology Pipeline

Global Phase 3 studies started for bomedemstat , nemtabrutinib , MK-2870 and MK-5684 Comprehensive clinical development programs being initiated for each investigational candidate Demonstrates...
United States Drug Administration Exchange Commission Merck Co Inc American Society For Hematology Merck Research Laboratories

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami

NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, announced today that it has received approval from the University of Miami to enroll...
Robb Knie Hoth Therapeutics Inc Washington University Of St Lr Advisors Md Anderson Cancer Center Exchange Commission

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Receive Public Listing for Patients with Advanced Endometrial Carcinoma (EC) that is not MSI-H or dMMR

KIRKLAND, QC, and MISSISSAUGA, ON, Dec. 21, 2023 /CNW/ - Merck , known as MSD outside the United States and Canada, and Eisai announce that KEYTRUDA®, Mercks anti-PD-1 therapy, plus LENVIMA®, an...
New Zealand United States United Kingdom Michele Randazzo Damini Chokshi Patrick Forsythe

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science